CIM CHIMERA INVESTMENT CORP

NYSE chimerareit.com


$ 13.02 $ 0.15 (1.17 %)    

Tuesday, 14-Oct-2025 15:59:58 EDT
QQQ $ 598.50 $ -4.01 (-0.67 %)
DIA $ 463.08 $ 2.03 (0.44 %)
SPY $ 662.74 $ -0.81 (-0.12 %)
TLT $ 90.69 $ 0.29 (0.32 %)
GLD $ 382.95 $ 2.70 (0.71 %)
$ 13.02
$ 12.77
$ 12.80 x 100
$ 13.05 x 1
$ 12.73 - $ 13.04
$ 9.33 - $ 14.58
609,004
na
1.06B
$ 1.31
$ 10.02
TBD
na
na ($ 0.11)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2025 06-30-2025 10-Q
2 05-08-2025 03-31-2025 10-Q
3 02-19-2025 12-31-2024 10-K
4 11-06-2024 09-30-2024 10-Q
5 08-07-2024 06-30-2024 10-Q
6 05-09-2024 03-31-2024 10-Q
7 02-29-2024 12-31-2023 10-K
8 11-02-2023 09-30-2023 10-Q
9 08-03-2023 06-30-2023 10-Q
10 05-04-2023 03-31-2023 10-Q
11 02-17-2023 12-31-2022 10-K
12 11-03-2022 09-30-2022 10-Q
13 08-04-2022 06-30-2022 10-Q
14 05-05-2022 03-31-2022 10-Q
15 02-17-2022 12-31-2021 10-K
16 11-03-2021 09-30-2021 10-Q
17 08-04-2021 06-30-2021 10-Q
18 05-06-2021 03-31-2021 10-Q
19 02-18-2021 12-31-2020 10-K
20 11-05-2020 09-30-2020 10-Q
21 08-06-2020 06-30-2020 10-Q
22 05-07-2020 03-31-2020 10-Q
23 02-24-2020 12-31-2019 10-K
24 10-31-2019 09-30-2019 10-Q
25 08-01-2019 06-30-2019 10-Q
26 05-02-2019 03-31-2019 10-Q
27 02-21-2019 12-31-2018 10-K
28 11-01-2018 09-30-2018 10-Q
29 08-02-2018 06-30-2018 10-Q
30 05-03-2018 03-31-2018 10-Q
31 02-20-2018 12-31-2017 10-K
32 11-02-2017 09-30-2017 10-Q
33 08-03-2017 06-30-2017 10-Q
34 05-04-2017 03-31-2017 10-Q
35 02-21-2017 12-31-2016 10-K
36 11-03-2016 09-30-2016 10-Q
37 08-04-2016 06-30-2016 10-Q
38 05-04-2016 03-31-2016 10-Q
39 02-25-2016 12-31-2015 10-K
40 11-05-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 chimera-investment-q2-adj-eps-039-misses-046-estimate-sales-66010m-miss-81395m-estimate

Chimera Investment (NYSE:CIM) reported quarterly earnings of $0.39 per share which missed the analyst consensus estimate of $0....

 ubs-maintains-buy-on-chimera-investment-raises-price-target-to-16

UBS analyst Douglas Harter maintains Chimera Investment (NYSE:CIM) with a Buy and raises the price target from $15 to $16.

 keefe-bruyette--woods-maintains-market-perform-on-chimera-investment-lowers-price-target-to-15

Keefe, Bruyette & Woods analyst Bose George maintains Chimera Investment (NYSE:CIM) with a Market Perform and lowers the...

 homexpress-mortgage-to-be-acquired-by-chimera-investment-corp-in-definitive-agreement-no-financial-terms-disclosed

HomeXpress Mortgage Corp. ("HomeXpress"), a leading national originator of non-QM and business-purpose residential mort...

 chimera-expands-mortgage-reach-with-homexpress-acquisition

Chimera Investment Corp (CIM) to acquire HomeXpress Mortgage Corp for $120M in cash and stock. Deal to expand mortgage loan ori...

 chimera-to-acquire-homexpress-for-120m-plus-208m-shares-to-expand-loan-origination

Chimera Investment Corporation (NYSE:CIM) ("Chimera") today announced that on June 11, 2025, it entered into a definiti...

 ubs-upgrades-chimera-investment-to-buy-raises-price-target-to-15

UBS analyst Douglas Harter upgrades Chimera Investment (NYSE:CIM) from Neutral to Buy and raises the price target from $11.5...

 stocks-trim-losses-after-hot-inflation-bonds-remain-pressured-tesla-rebounds-whats-driving-markets-wednesday

A hotter-than-expected inflation report initially rattled markets on Wednesday morning, but investors found confidence to buy t...

 chimera-investment-q4-2024-sales-6582m-miss-7755m-estimate

Chimera Investment (NYSE:CIM) reported quarterly earnings of $0.37 per share which missed the analyst consensus estimate of $0....

 chimera-investment-q4-2024-adj-eps-037-misses-047-estimate

Chimera Investment (NYSE:CIM) reported quarterly earnings of $0.37 per share which missed the analyst consensus estimate of $0....

 jmp-securities-reiterates-market-perform-on-chimera-investmentto-market-perform

JMP Securities analyst Aaron Hecht reiterates Chimera Investment (NYSE:CIM) from Market Perform to Market Perform.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION